Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Monte Rosa Therapeutics (GLUE) Prepaid Assets: 2023-2025

Historic Prepaid Assets for Monte Rosa Therapeutics (GLUE) over the last 3 years, with Sep 2025 value amounting to $5.6 million.

  • Monte Rosa Therapeutics' Prepaid Assets fell 33.61% to $5.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.6 million, marking a year-over-year decrease of 33.61%. This contributed to the annual value of $5.1 million for FY2024, which is 55.37% up from last year.
  • Latest data reveals that Monte Rosa Therapeutics reported Prepaid Assets of $5.6 million as of Q3 2025, which was down 13.95% from $6.5 million recorded in Q2 2025.
  • In the past 5 years, Monte Rosa Therapeutics' Prepaid Assets ranged from a high of $8.4 million in Q3 2024 and a low of $3.3 million during Q4 2023.
  • Its 3-year average for Prepaid Assets is $5.3 million, with a median of $5.5 million in 2024.
  • As far as peak fluctuations go, Monte Rosa Therapeutics' Prepaid Assets skyrocketed by 103.53% in 2024, and later tumbled by 33.61% in 2025.
  • Quarterly analysis of 3 years shows Monte Rosa Therapeutics' Prepaid Assets stood at $3.3 million in 2023, then soared by 55.37% to $5.1 million in 2024, then slumped by 33.61% to $5.6 million in 2025.
  • Its Prepaid Assets stands at $5.6 million for Q3 2025, versus $6.5 million for Q2 2025 and $4.8 million for Q1 2025.